News
Trestle Biotherapeutics Joins the Wellcome Leap HOPE Program
Company Context
- Market
- Biotech
- Stage
- Seed
Key Highlight
Trestle Biotherapeutics announced a research collaboration with Humacyte in March 2025 to develop bioengineered kidney tissues.
More from Trestle Biotherapeutics
More Biotech News
- ColossalColossal Biosciences Reawakens the Dire WolfMar 2026
- MinicircleKlotho Gene Therapy launching in 2026Mar 2026
- ColossalColossal Foundation Doubles Funding to $100MJan 2026
- ColossalColossal Foundation raised $50 millionDec 2025
- AetherRaised $15M to reindustrialize America with AI-designed proteinsDec 2025